Correlation Between GlaxoSmithKline PLC and BK Technologies

Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and BK Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and BK Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and BK Technologies, you can compare the effects of market volatilities on GlaxoSmithKline PLC and BK Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of BK Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and BK Technologies.

Diversification Opportunities for GlaxoSmithKline PLC and BK Technologies

-0.89

Correlation Coefficient

GlaxoSmithKline PLC  BK Technologies

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and BKTI is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and BK Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BK Technologies and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with BK Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BK Technologies has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and BK Technologies go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and BK Technologies

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the BK Technologies. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 3.64 times less risky than BK Technologies. The stock trades about -0.23 of its potential returns per unit of risk. The BK Technologies is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  2,219  in BK Technologies on August 31, 2024 and sell it today you would earn a total of  1,128  from holding BK Technologies or generate 50.83% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

GlaxoSmithKline PLC ADR  vs.  BK Technologies

GlaxoSmithKline PLC ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

BK Technologies

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in BK Technologies are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, BK Technologies demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with GlaxoSmithKline PLC and BK Technologies

The main advantage of trading using opposite GlaxoSmithKline PLC and BK Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, BK Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BK Technologies will offset losses from the drop in BK Technologies' long position.

The idea behind GlaxoSmithKline PLC ADR and BK Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..